Has ACR made comment about the sales figures posted by Eli Lilly with regard to Axiron in their most recent earnings call?
Q1 - 0
Q2 - 2.2
Q3 - 5.2
Q4 - 15.5
Total is showing 24.0, obviously the quarters do not add up to that.
- Forums
- ASX - By Stock
- ACR
- Eli Lilly results and cnbc interview 2nite
ACR
acrux limited
Add to My Watchlist
5.88%
!
1.6¢

Eli Lilly results and cnbc interview 2nite, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.6¢ |
Change
-0.001(5.88%) |
Mkt cap ! $6.524M |
Open | High | Low | Value | Volume |
1.7¢ | 1.7¢ | 1.5¢ | $17.57K | 1.064M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 332898 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.6¢ | 75620 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 332898 | 0.015 |
2 | 320000 | 0.014 |
2 | 397000 | 0.013 |
1 | 80000 | 0.012 |
2 | 150000 | 0.010 |
Price($) | Vol. | No. |
---|---|---|
0.016 | 75620 | 1 |
0.017 | 674874 | 3 |
0.018 | 322359 | 3 |
0.019 | 677115 | 3 |
0.020 | 50000 | 1 |
Last trade - 15.40pm 25/06/2025 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |